Cargando…
Preference for Immunotherapy with Tablets by People with Allergic Rhinitis
BACKGROUND: People with allergic rhinitis (AR) who are not controlled on conventional therapy can be treated using allergy immunotherapy (AIT) administered as tablets, injections or drops. In the US, the use of sublingual immunotherapy as tablets (SLIT-tablets) is limited in comparison to subcutaneo...
Autores principales: | Tankersley, Mike, Winders, Tonya, Aagren, Mark, Brandi, Henrik, Hasse Pedersen, Mikkel, Ledgaard Loftager, Anne Sofie, Bøgelund, Mette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608245/ https://www.ncbi.nlm.nih.gov/pubmed/34819723 http://dx.doi.org/10.2147/PPA.S338337 |
Ejemplares similares
-
Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis
por: Bøgelund, Mette, et al.
Publicado: (2022) -
Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
por: Lombardi, Carlo, et al.
Publicado: (2017) -
Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011) -
Mechanisms of Allergen Immunotherapy in Allergic Rhinitis
por: Drazdauskaitė, Gabija, et al.
Publicado: (2020) -
Immunotherapy in the Treatment of Allergic Rhinitis in Children
por: Alamri, Ruba A, et al.
Publicado: (2022)